MENU
+Compare
JSPR
Stock ticker: NASDAQ
AS OF
Dec 17, 04:59 PM (EDT)
Price
$22.47
Change
+$1.02 (+4.76%)
Capitalization
321.78M

JSPR Jasper Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for JSPR with price predictions
Dec 17, 2024

JSPR in +8.98% Uptrend, rising for three consecutive days on December 17, 2024

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where JSPR advanced for three days, in of 197 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 60 cases where JSPR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

JSPR moved above its 50-day moving average on December 16, 2024 date and that indicates a change from a downward trend to an upward trend.

JSPR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 134 cases where JSPR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for JSPR moved out of overbought territory on November 12, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on December 10, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on JSPR as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for JSPR turned negative on December 05, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where JSPR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. JSPR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.024) is normal, around the industry mean (14.664). P/E Ratio (0.000) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). JSPR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (260.687).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. JSPR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

JSPR is expected to report earnings to fall 4.38% to -152 cents per share on March 15

Jasper Therapeutics JSPR Stock Earnings Reports
Q4'23
Est.
$-1.53
Q3'23
Missed
by $1.44
Q2'23
Est.
$-0.15
Q1'23
Est.
$-0.16
Q4'22
Missed
by $3.23
The last earnings report on November 09 showed earnings per share of -160 cents, missing the estimate of -15 cents. With 286.19K shares outstanding, the current market capitalization sits at 321.78M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2200 Bridge Parkway
Phone
+1 650 549-1400
Employees
45
Web
https://www.jaspertherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NUEIX22.01N/A
N/A
Northern US Quality ESG I
ALIBX12.55N/A
N/A
ALPS/Smith Balanced Opportunity Inv
DILCX12.33-0.04
-0.32%
Davis International C
HHHYX17.34-0.09
-0.52%
Hartford Schroders Emerging Mkts Eq Y
PKAAX13.20-0.07
-0.53%
PIMCO RAE US A

JSPR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, JSPR has been loosely correlated with AUPH. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if JSPR jumps, then AUPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JSPR
1D Price
Change %
JSPR100%
+4.66%
AUPH - JSPR
44%
Loosely correlated
-0.83%
OMGA - JSPR
43%
Loosely correlated
+0.15%
IMNM - JSPR
42%
Loosely correlated
-3.38%
ATNF - JSPR
38%
Loosely correlated
N/A
ATXI - JSPR
34%
Loosely correlated
-4.60%
More